By A Mystery Man Writer
“And people are dying. About 20% of all our patients together are actually dying before they can get CAR-T,” said Krina Patel, director of the myeloma cell therapy program at MD Anderson.
Manufacturing challenge leads to death in CAR-T trial
CAR T treatment beyond cancer: Hope for immunomodulatory therapy of non-cancerous diseases - ScienceDirect
The Application of CAR-T in Disease Treatment – Creative Biolabs Blog
Off-the-Shelf CAR T Cell Therapy for Multiple Myeloma Shows Promise
Need CAR T cell therapy? Here's what to expect
China Medical University Hospital collaborates with Ever Supreme Bio Technology to jointly develop new anti-cancer weapon - Chimeric antigen receptor immune cell therapy
The Latest in CAR-T Cell Therapy for Pediatric Cancer
Living drug' offers hope to terminal blood cancer patients - BBC News
Mechanisms of resistance to CAR T cell therapy
Success Story: Canadian cancer survivor works with the NRC for broader access to CAR-T therapy